NCT04650581 2026-04-13
FINER
Canadian Cancer Trials Group
Phase 3 Active not recruiting
Clinical Trials
5 trialsNCT03425838 2025-09-19
Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer
Borstkanker Onderzoek Groep
Phase 3 Active not recruiting
NCT02137837 2021-01-28
S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer
SWOG Cancer Research Network
Phase 3 Terminated
NCT00075764 2021-01-13
S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
SWOG Cancer Research Network
Phase 3 Completed
NCT00010153 2012-07-19
ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Terminated